Zhaoxiang Cheng – Trademark Portfolio

Entity Type: 01

Zhaoxiang Cheng holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 20 (Furniture) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include ASCMARN, IDKETSO, and POSLIFE. The owner is based in Bengbu,Anhui.

No.1866,Caoshan Road

Bangshan Dist

Bengbu,Anhui 233000 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ASCMARN
ASCMARN
Registered 2020
IDKETSO
IDKETSO
Registered 2020
POSLIFE
POSLIFE
Registered 2020

Trademark Classifications

Zhaoxiang Cheng's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

20
Furniture (1 filing)

Furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker

Frequently Asked Questions

How many trademarks does Zhaoxiang Cheng have?

Zhaoxiang Cheng has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Zhaoxiang Cheng file in?

Zhaoxiang Cheng files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 20 (Furniture). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Zhaoxiang Cheng's most well-known trademarks?

Zhaoxiang Cheng's registered trademark portfolio includes well-known marks such as ASCMARN, IDKETSO, and POSLIFE. These are among 3 currently registered trademarks in the portfolio.

What is Zhaoxiang Cheng's trademark registration success rate?

Zhaoxiang Cheng has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.